In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice

Journal of Immunology

Volumn 181, Issue 11, 2009, Pages 8133-8144

  Zekavat, Ghazal ^a   Rostami, Susan Y ^a   Badkerhanian, Armen ^a   Parsons, Ronald F ^a   Koeberlein, Brigitte ^a   Yu, Ming ^a   Ward, Christopher D ^b   Migone, Thi Sau ^b   Yu, Liping ^c   Eisenbarth, George S ^c   Cancro, Michael P ^a   Naji, Ali ^a   Noorchashm, Hooman ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; B CELL ACTIVATING FACTOR; INSULIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DESTRUCTION; CELL SELECTION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HYPOTHESIS; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET CELL; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

EID: 71849093408     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.11.8133     Document Type: Article

References (44)

1. Silveira, P. A., and S. T. Grey. 2006. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes. Trends Endocrinol. Metab. 17: 128-135.
2. Miao, D., L. Yu, and G. S. Eisenbarth. 2007. Role of autoantibodies in type 1 diabetes. Front. Biosci. 12: 1889-1898.
3. Zhang, L., M. Nakayama, and G. S. Eisenbarth. 2008. Insulin as an autoantigen in NOD/human diabetes. Curr. Opin. Immunol. 20: 111-118.
4. Serreze, D. V., H. D. Chapman, D. S. Varnum, M. S. Hanson, P. C. Reifsnyder, S. D. Richard, S. S. Fleming, E. H. Leiter, and L. D. Shultz. 1996. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD. Ig mu null mice. J. Exp. Med. 184: 2049-2053.
5. Noorchashm, H., N. Noorchashm, J. Kern, S. Y. Rostami, C. F. Barker, and A. Naji. 1997. B cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 46: 941-946. (Pubitemid 27220992)
6. Chiu, P. P., D. V. Serreze, and J. S. Danska. 2001. Development and function of diabetogenic T-cells in B cell-deficient nonobese diabetic mice. Diabetes 50: 763-770. (Pubitemid 32242632)
7. Falcone, M., J. Lee, G. Patstone, B. Yeung, and N. Sarvetnick. 1998. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J. Immunol. 161: 1163-1168. (Pubitemid 28380541)
8. Noorchashm, H., Y. K. Lieu, N. Noorchashm, S. Y. Rostami, S. A. Greeley, A. Schlacterman, H. K. Song, L. E. Noto, A. M. Jevnikar, C. F. Barker, and A. Naji. 1999. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet β cells of nonobese diabetic mice. J. Immunol. 163: 743-750. (Pubitemid 29328081)
9. Serreze, D. V., S. A. Fleming, H. D. Chapman, S. D. Richard, E. H. Leiter, and R. M. Tisch. 1998. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 161: 3912-3918. (Pubitemid 28468965)
10. Serreze, D. V., and P. A. Silveira. 2003. The role of B lymphocytes as key antigen-presenting cells in the development of T cell-mediated autoimmune type 1 diabetes. Curr. Dir. Autoimmun. 6: 212-227.
11. Silveira, P. A., E. Johnson, H. D. Chapman, T. Bui, R. M. Tisch, and D. V. Serreze. 2002. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur. J. Immunol. 32: 3657-3666.
12. Quinn, W. J., III, N. Noorchashm, J. E. Crowley, A. J. Reed, H. Noorchashm, A. Naji, and M. P. Cancro. 2006. Cutting edge: impaired transitional B cell production and selection in the nonobese diabetic mouse. J. Immunol. 176: 7159-7164.
13. Hulbert, C., B. Riseili, M. Rojas, and J. W. Thomas. 2001. B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J. Immunol. 167: 5535-5538. (Pubitemid 33062740)
14. Miller, J. P., J. E. Stadanlick, and M. P. Cancro,. 2006. Space, selection, and surveillance: setting boundaries with BLyS. J. Immunol. 176: 6405-6410.
15. Harless, S. M., V. M. Lentz, A. P Sah, B. L. Hsu, K. Clise-Dwyer, D. M. Hilbert, C. E. Hayes, and M. P. Cancro. 2001. Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers. Curr. Biol. 11: 1986-1989.
16. Miller, D. J., K. D. Hanson, J. A. Carman, and C. E. Hayes. 1992. A single autosomal gene defect severely limits IgG but not IgM responses in B lymphocyte-deficient A/WySnJ mice. Eur. J. Immunol. 22: 373-379.
17. Vora, K. A., L. C. Wang, S. P. Rao, Z. Y. Liu, G. R. Majeau, A. H. Cutler, P. S. Hochman, M. L. Scott, and S. L. Kalled. 2003. Cutting edge: germinal centers formed in the absence of B cell-activating factor belonging to the TNF family exhibit impaired maturation and function. J. Immunol. 171: 547-551.
18. Lentz, V. M., M. P. Cancro, F. E. Nashold, and C. E. Hayes. 1996. Bcmd governs recruitment of new B cells into the stable peripheral B cell pool in the A/WySnJ mouse. J. Immunol. 157: 598-606.
19. Lentz, V. M., C. E. Hayes, and M. P. Cancro. 1998. Bcmd decreases the life span of B-2 but not B-1 cells in A/WySnJ mice. J. Immunol. 160: 3743-3747.
20. Thien, M., T. G. Phan, S. Gardam, M. Amesbury, A. Basten, F. Mackay, and R. Brink. 2004. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20: 785-798. (Pubitemid 38757447)
21. Lesley, R., Y. Xu, S. L. Kalled, D. M. Hess, S. R. Schwab, H. B. Shu, and J. G. Cyster. 2004. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 20: 441-453. (Pubitemid 38482122)
22. Mackay, F., and J. L. Browning. 2002. BAFF: a fundamental survival factor for B cells. Nat. Rev. Immunol. 2: 465-475. (Pubitemid 37328738)
23. Khare, S. D., I. Sarosi, X. Z. Xia, S. McCabe, K. Miner, I. Solovyev, N. Hawkins, M. Kelley, D. Chang, G. Van, et al. 2000. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. USA 97: 3370-3375.
24. Mackay, F., S. A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp, and J. L. Browning. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190: 1697-1710. (Pubitemid 30002351)
25. Treml, L. S., G. Carlesso, K. L. Hoek, J. E. Stadanlick, T. Kambayashi, R. J. Bram, M. P. Cancro, and W. N. Khan. 2007. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J. Immunol. 178: 7531-7539.
26. Cambridge, G., W. Stohl, M. J. Leandro, T. S. Migone, D. M. Hilbert, and J.C. Edwards. 2006. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis Rheum. 54: 723-732.
27. Lindsley, R. C., M. Thomas, B. Srivastava, and D. Allman. 2007. Generation of peripheral B cells occurs via two spatially and temporally distinct pathways. Blood 109: 2521-2528.
28. Abdul-Rasoul, M., H. Habib, and M. Al-Khouly. 2006. "The honeymoon phase" in children with type 1 diabetes mellitus: frequency, duration, and influential factors. Pediatr. Diabetes 7: 101-107.
29. Noorchashm, H., D. J. Moore, L. E. Noto, N. Noorchashm, A. J. Reed, A. L. Reed, H. K. Song, R. Mozaffari, A. M. Jevnikar, C. F. Barker, and A. Naji. 2000. Impaired CD4 T cell activation due to reliance upon B cell-mediated co-stimulation in nonobese diabetic (NOD) mice. J. Immunol. 165: 4685-4696. (Pubitemid 30795851)
30. Greeley, S. A. D., J. Moore, H. Noorchashm, L. E. Noto, S. Y. Rostami, A. Schlachterman, H. K. Song, B. Koeberlein, C. F. Barker, and A. Naji. 2001. Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice. J. Immunol. 167: 4351-4357.
31. Xiu, Y., C. P. Wong, J. D. Bouaziz, Y. Hamaguchi, Y. Wang, S. M. Pop, R. M. Risch, and T. F. Tedder. 2008. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in FcγR effector functions. J. Immunol. 180: 2863-2875.
32. Hu, C. Y., D. Rodriguez-Pinto, W. Du, A. Ahuja, O. Henegariu, F. S. Wong, M. J. Shlomchik, and L. Wen. 2007. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J. Clin. Invest. 117: 3857-3867. (Pubitemid 350224095)
33. Cyster, J. G., and C. C. Goodnow. 1995. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity 3: 691-701.
34. Cyster, J. G., S. B. Hartley, and C. C. Goodnow. 1994. Competition for follicular niches excludes self-reactive cells from the recirculating B cell repertoire. Nature 371: 389-395.
35. Mandik-Nayak, L., A. Bui, H. Noorchashm, A. Eaton, and J. Erikson. 1997. Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J. Exp. Med. 186: 1257-1267. (Pubitemid 27469021)
36. Cancro, M. P. 2004. The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation. Immunol. Rev. 202: 237-249.
37. Mariño, E., M. Batten, J. Groom, S. Walters, D. Liuwantara, F. Mackay, and S. T. Grey. 2008. Marginal-zone B cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes 57: 395-404.
38. Rolf, J., V. Motta, N. Duarte, M. Lundholm, E. Berntman, M. L. Bergman, L. Sorokin, S. L. Cardell, and D. Holmberg. 2005. The enlarged population of marginal zone/CD1dhigh B lymphocytes in non obese diabetic mice maps to diabetes susceptibility region Idd11. J. Immunol. 174: 4821-4827. (Pubitemid 40504565)
39. Noorchashm, H., D. J. Moore, Y. K. Lieu, N. Noorchashm, A. Schlachterman, H. K. Song, C. F. Barker, and A. Naji. 1999. Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors. Cell. Immunol. 195: 75-79. (Pubitemid 29384265)
40. Chatenoud, L., B. Salomon, and J. A. Bluestone. 2001. Suppressor T cells: they're back and critical for regulation of autoimmunity! Immunol. Rev. 182: 149-163. (Pubitemid 33070215)
41. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
42. Baker, K. P., B. M. Edwards, S. H. Main, G. H. Choi, R. E. Wager, W. G. Halpern. P. B. Lappin, T. Riccobene, D. Abramian, L. Sekut, et al. 2003. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis Rheum. 48: 3253-3265.
43. Ding, C., and G. Jones. 2006. Belimumab human genome sciences/Cambridge antibody technology/GlaxoSmithKline. Curr. Opin. Investig. Drugs 7: 464-472. (Pubitemid 43772987)
44. Bayes, M., X. Rabasseda, and J. R. Prous. 2007. Gateways to clinical trials. Methods Find. Exp. Clin. Pharmacol. 29: 697-735.